Clinical Trial Update: Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy of Fansidar (pyrimethamine/sulfadoxine) for treating uncomplicated malaria caused by Plasmodium falciparum in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Fansidar (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Walter Reed Army Institute of Research (WRAIR) | Conditions: Malaria, Vivax, Malaria, Falciparum | NA | Status: COMPLETED